Insulet Corp. (PODD)
145.63
-2.53
(-1.71%)
USD |
NASDAQ |
Aug 24, 16:00
145.50
-0.13
(-0.09%)
After-Hours: 20:00
Insulet Total Assets (Quarterly) : 3.165B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.165B |
| March 31, 2026 | 2.987B |
| December 31, 2025 | 3.190B |
| September 30, 2025 | 3.029B |
| June 30, 2025 | 3.469B |
| March 31, 2025 | 3.517B |
| December 31, 2024 | 3.088B |
| September 30, 2024 | 3.025B |
| June 30, 2024 | 2.882B |
| March 31, 2024 | 2.624B |
| December 31, 2023 | 2.588B |
| September 30, 2023 | 2.468B |
| June 30, 2023 | 2.386B |
| March 31, 2023 | 2.289B |
| December 31, 2022 | 2.251B |
| September 30, 2022 | 2.166B |
| June 30, 2022 | 2.114B |
| March 31, 2022 | 2.069B |
| December 31, 2021 | 2.049B |
| September 30, 2021 | 1.999B |
| June 30, 2021 | 1.924B |
| March 31, 2021 | 1.840B |
| December 31, 2020 | 1.873B |
| September 30, 2020 | 1.711B |
| June 30, 2020 | 1.627B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.108B |
| December 31, 2019 | 1.143B |
| September 30, 2019 | 1.268B |
| June 30, 2019 | 977.72M |
| March 31, 2019 | 952.61M |
| December 31, 2018 | 928.74M |
| September 30, 2018 | 886.31M |
| June 30, 2018 | 838.86M |
| March 31, 2018 | 829.76M |
| December 31, 2017 | 816.74M |
| September 30, 2017 | 500.35M |
| June 30, 2017 | 459.33M |
| March 31, 2017 | 444.96M |
| December 31, 2016 | 456.65M |
| September 30, 2016 | 453.20M |
| June 30, 2016 | 263.04M |
| March 31, 2016 | 254.77M |
| December 31, 2015 | 275.13M |
| September 30, 2015 | 293.12M |
| June 30, 2015 | 300.39M |
| March 31, 2015 | 305.72M |
| December 31, 2014 | 302.16M |
| September 30, 2014 | 301.20M |
| June 30, 2014 | 325.33M |
| March 31, 2014 | 288.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 109.22B |
| DexCom, Inc. | 6.455B |
| Boston Scientific Corp. | 45.22B |
| PROCEPT BioRobotics Corp. | 479.35M |
| Globus Medical, Inc. | 5.488B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.743B |
| Shareholders Equity (Quarterly) | 1.422B |
| Debt to Equity Ratio | 0.6669 |
| Current Ratio | 2.448 |
| Net Debt Paydown Yield | 1.41% |